Werlinich Asset Management, LLC Embecta Corp. Transaction History

Werlinich Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 13, 2023	SELL	$23.07 - $32.77 $212,820 - $302,303	-9,225 Closed	0 $0
Q4 2022 Nov 13, 2023	SELL	$25.29 - $35.48 $12,645 - $17,740	-500 Reduced 5.14%	9,225 $233 Million
Q3 2022 Nov 13, 2023	SELL	$24.0 - $33.42 $8,400 - $11,697	-350 Reduced 3.47%	9,725 $280 Million
Q2 2022 Nov 13, 2023	BUY	$24.78 - $33.36 $249,658 - $336,102	10,075 New	10,075 $255 Million

398

52.9M

215K

83.3K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $774M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Werlinich Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Werlinich Asset Management, LLC with notifications on news.